NCT02419820View on ClinicalTrials.gov

Dose-escalation, Repeated and Single Oral Dosing Study

PHASE1TerminatedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Acute Coronary Syndrome
Interventions
DRUG

APD791

Temanogrel

DRUG

Clopidogrel

Clopidogrel

DRUG

Aspirin

Aspirin

DRUG

Placebo for APD791

Placebo for APD791

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

IlDong Pharmaceutical Co Ltd

INDUSTRY